PATIENT'S VIEW ON THE TREATMENT OF DIFFUSE FORM ALOPECIA ASSOCIATED WITH COVID-19
*U. Tashkenbayeva and F. Abboskhonova
ABSTRACT
The purpose of the study to analyze the subjective assessment of the effectiveness of treatment of patients with diffuse form of alopecia associated with COVID-19 based on a medical and sociological survey. Materials and Methods. The study included a survey of 129 patients who received therapy for diffuse alopecia associated with COVID-19. As a comparison, an analysis was made between 82 (n1=100%) patients undergoing complex therapy using the dietary supplement "Vitamineralle" in combination with a physiotherapy technique using the Sincery laser device model BS-LL7H (Republic of Korea) and 42 (n2=100%) patients who received standard therapy in accordance with the recommendations for the treatment of patients with alopecia in the Republic of Uzbekistan. Directly, the subjective assessment questionnaire included five questions on the dynamics of growth and general appearance of hair, the degree of satisfaction with the treatment, the size of the area of baldness and visual satisfaction. Results. Taking into account the data obtained, it was noted that the majority, 70 (85.4%) patients receiving combination therapy express a positive assessment in connection with satisfaction with the treatment of DA associated with COVID-19. Compared with 23 (48.9%) patients who received standard therapy who are not satisfied with the result of the treatment. When evaluating the answers to questions: No. 1 (changes in the area of baldness after a course of treatment), No. 2 (changes in the appearance of hair after a course of treatment), No. 3 (changes in hair growth after a course of treatment), No. 4 (evaluation of the effectiveness of a course of treatment), No. 5 (degree of satisfaction with hair growth depending on the area of the scalp), statistically significant differences were found (p
[Full Text Article] [Download Certificate]